Clinical, laboratory and instrumental characteristics of children with sydenham’s chorea


Cite item

Abstract

Sydenham's chorea (SC) is a major clinical criterion in acute rheumatic fever (RF). SC is a late neurological manifestation of acute rheumatic fever which occurs 1 to 6 months after pharyngeal infection with group A betahemolytic streptococci. SC is characterized by clinical symptoms: involuntary hyperkinetic movements, muscular hypotonia, hyperreflexia, gait disturbance, emotional lability. Objective: The aim of the study was to identify frequency, clinical manifestations and the treatment of SC. The study included 56 children 4-17 years old, who were hospitalized in the Morozovskaya children’s clinical city hospital in 2001-2015 with RF. Clinical history, laboratory and instrumental methods (electrocardiography, transthoracic echocardiogram, cranial computed tomography scan and/or magnetic resonance imaging, electroencephalography, electroneuromyography). The study revealed frequent errors (66%) in RF diagnosis before hospitalization. Besides chorea, the clinical manifestations of RF were: carditis (89,3%), arthritis (46,4%), erythema marginatum (10,7%), subcutaneous nodule (1,8%). The peculiarity of our study washighfrequency of chorea (42,9%). Isolated chorea wasseen in 12,5%, mixed chorea - in 30,4% of SC. The clinical manifestations of chorea were typical. The nervous system lesion most often occured in children with a neurological history (p < 0,05). The clinical or laboratory evidence of streptococcal infection were seldom found (p = 0,02) in patients withchorea (45,8%) compared with patients without chorea symptoms (69%). RF issue requires attention from the medical community. SC, especially isolated chorea (29%), is the most challenging manifestation of RF for the differential diagnosis.Chronic rheumatic heart disease can be developed even in patients with isolated chorea (12,5%). In the treatment of SC in addition antibiotics and drugs which affect domamine and GABA metabolism, glucocorticoids (Prednisolone) are needed.

About the authors

M G Kantemirova

RUDN University

Email: kantemirova60@mail.ru
Morozovskaya children’s city clinical hospital Moscow, Russia

Yu Yu Novikova

RUDN University

Email: 8newyu8@mail.ru
Moscow, Russia

O A Korovina

RUDN University

Email: o.korovina2013@yandex.ru
Morozovskaya children’s city clinical hospital Moscow, Russia

I M Drozdova

Morozovskaya children’s city clinical hospital

Email: Irina.drozdova@mail.ru
Moscow, Russia

E A Degtyareva

RUDN University

Email: dib6@yandex.ru
Moscow, Russia

D Yu Ovsyannikov

RUDN University

Email: mdovsyannikov@yahoo.com
Morozovskaya children’s city clinical hospital Moscow, Russia

I E Koltunov

RUDN University

Email: info@mdgkb.mosgorzdrav.ru
Morozovskaya children’s city clinical hospital Moscow, Russia

References


Copyright (c) 2017 Кантемирова М.Г., Новикова Ю.Ю., Коровина О.А., Дроздова И.М., Дегтярева Е.А., Овсянников Д.Ю., Колтунов И.Е.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies